Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 8.936
Filter
1.
Food Res Int ; 183: 114223, 2024 May.
Article in English | MEDLINE | ID: mdl-38760142

ABSTRACT

This study investigates the potential of κ-carrageenan hydrogel beads as a delivery system for curcumin, a bioactive compound with various health benefits. Hydrogel beads were prepared using the extrusion technique with a hypodermic needle. The encapsulation efficiency of curcumin in the κ-carrageenan hydrogel beads was found to be 74.61 ± 3.2 %. FTIR spectroscopy analysis revealed shifts in absorption peaks, indicating possible hydrogen bonding and/or ionic interactions between the polymer and salt. An increase in the melting point of curcumin, by 25 °C, in curcumin- κ-carrageenan beads suggests the heat protection offered by the carrageenan chains to curcumin molecules. The in vitro release of curcumin from the beads suggests a sustained and pH-dependent release nature. The release kinetics follow the first order and the Korsmeyer-Peppas model. The outcome offers value-added delivery systems of bioactive compounds toward developing novel food and pharmaceutical applications.


Subject(s)
Carrageenan , Curcumin , Delayed-Action Preparations , Dietary Supplements , Hydrogels , Curcumin/chemistry , Carrageenan/chemistry , Hydrogels/chemistry , Spectroscopy, Fourier Transform Infrared , Hydrogen-Ion Concentration , Drug Liberation , Drug Delivery Systems , Kinetics , Colloids/chemistry , Drug Carriers/chemistry
2.
J Vis Exp ; (207)2024 May 03.
Article in English | MEDLINE | ID: mdl-38767380

ABSTRACT

Embedded three-dimensional (3D) bioprinting utilizing a granular hydrogel supporting bath has emerged as a critical technique for creating biomimetic scaffolds. However, engineering a suitable gel suspension medium that balances precise bioink deposition with cell viability and function presents multiple challenges, particularly in achieving the desired viscoelastic properties. Here, a novel κ-carrageenan gel supporting bath is fabricated through an easy-to-operate mechanical grinding process, producing homogeneous sub-microscale particles. These sub-microgels exhibit typical Bingham flow behavior with small yield stress and rapid shear-thinning properties, which facilitate the smooth deposition of bioinks. Moreover, the reversible gel-sol transition and self-healing capabilities of the κ-carrageenan microgel network ensure the structural integrity of printed constructs, enabling the creation of complex, multi-layered tissue structures with defined architectural features. Post-printing, the κ-carrageenan sub-microgels can be easily removed by a simple phosphate-buffered saline wash. Further bioprinting with cell-laden bioinks demonstrates that cells within the biomimetic constructs have a high viability of 92% and quickly extend pseudopodia, as well as maintain robust proliferation, indicating the potential of this bioprinting strategy for tissue and organ fabrication. In summary, this novel κ-carrageenan sub-microgel medium emerges as a promising avenue for embedded bioprinting of exceptional quality, bearing profound implications for the in vitro development of engineered tissues and organs.


Subject(s)
Bioprinting , Carrageenan , Carrageenan/chemistry , Bioprinting/methods , Microgels/chemistry , Printing, Three-Dimensional , Tissue Engineering/methods , Hydrogels/chemistry , Tissue Scaffolds/chemistry , Animals , Humans
3.
Sci Rep ; 14(1): 11047, 2024 05 14.
Article in English | MEDLINE | ID: mdl-38744989

ABSTRACT

Callicarpa kwangtungensis Chun (CK) is a common remedy exhibits anti-inflammatory properties and has been used in Chinese herbal formulations, such as KangGongYan tablets. It is the main component of KangGongYan tablets, which has been used to treat chronic cervicitis caused by damp heat, red and white bands, cervical erosion, and bleeding. However, the anti-inflammatory effects of CK water extract remains unknown. This study assessed the anti-inflammatory effects of CK in vivo and in vitro, characterized its main components in the serum of rats and verified the anti-inflammatory effects of serum containing CK. Nitric oxide (NO), tumour necrosis factor α (TNF-α) and interleukin-6 (IL-6) release by RAW264.7 cells was examined by ELISA and Griess reagents. Inflammation-related protein expression in LPS-stimulated RAW264.7 cells was measured by western blotting. Furthermore, rat model of foot swelling induced by λ-carrageenan and a collagen-induced arthritis (CIA) rat model were used to explore the anti-inflammatory effects of CK. The components of CK were characterized by LC-MS, and the effects of CK-containing serum on proinflammatory factors levels and the expression of inflammation-related proteins were examined by ELISA, Griess reagents and Western blotting. CK suppressed IL-6, TNF-α, and NO production, and iNOS protein expression in LPS-stimulated RAW264.7 cells. Mechanistic studies showed that CK inhibited the phosphorylation of ERK, P38 and JNK in the MAPK signaling pathway, promoted the expression of IκBα in the NF-κB signaling pathway, and subsequently inhibited the expression of iNOS, thereby exerting anti-inflammatory effects. Moreover, CK reduced the swelling rates with λ-carrageenan induced foot swelling, and reduced the arthritis score and incidence in the collagen-induced arthritis (CIA) rat model. A total of 68 compounds in CK water extract and 31 components in rat serum after intragastric administration of CK were characterized. Serum pharmacological analysis showed that CK-containing serum suppressed iNOS protein expression and NO, TNF-α, and IL-6 release. CK may be an anti-inflammatory agent with therapeutic potential for acute and chronic inflammatory diseases, especially inflammatory diseases associated with MAPK activation.


Subject(s)
Anti-Inflammatory Agents , Arthritis, Experimental , Nitric Oxide , Plant Extracts , Animals , Mice , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Rats , RAW 264.7 Cells , Plant Extracts/pharmacology , Plant Extracts/chemistry , Nitric Oxide/metabolism , Arthritis, Experimental/drug therapy , Water/chemistry , Carrageenan , Disease Models, Animal , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/blood , Male , Interleukin-6/metabolism , Interleukin-6/blood , Edema/drug therapy , Inflammation/drug therapy
4.
Nutr Diabetes ; 14(1): 28, 2024 May 16.
Article in English | MEDLINE | ID: mdl-38755184

ABSTRACT

Proglucagon mRNA expression and GLP-1 secretion by cultured human L-cells (NCI-H716) were inhibited following exposure to λ-carrageenan, a commonly used additive in processed foods. Carrageenan is composed of sulfated or unsulfated galactose residues linked in alternating alpha-1,3 and beta-1,4 bonds and resembles the endogenous sulfated glycosaminoglycans. However, carrageenan has unusual alpha-1,3-galactosidic bonds, which are not innate to human cells and are implicated in immune responses. Exposure to carrageenan predictably causes inflammation, and carrageenan impairs glucose tolerance and contributes to insulin resistance. When cultured human L-cells were deprived overnight of glucose and serum and then exposed to high glucose, 10% FBS, and λ-carrageenan (1 µg/ml) for 10 minutes, 1 h, and 24 h, mRNA expression of proglucagon and secretion of GLP-1 were significantly reduced, compared to control cells not exposed to carrageenan. mRNA expression of proglucagon by mouse L-cells (STC-1) was also significantly reduced and supports the findings in the human cells. Exposure of co-cultured human intestinal epithelial cells (LS174T) to the spent media of the carrageenan-treated L-cells led to a decline in mRNA expression of GLUT-2 at 24 h. These findings suggest that ingestion of carrageenan-containing processed foods may impair the production of GLP-1, counteract the effect of GLP-1 receptor agonists and induce secondary effects on intestinal epithelial cells.


Subject(s)
Carrageenan , Enteroendocrine Cells , Food Additives , Glucagon-Like Peptide 1 , Proglucagon , Carrageenan/pharmacology , Humans , Glucagon-Like Peptide 1/metabolism , Food Additives/pharmacology , Proglucagon/metabolism , Enteroendocrine Cells/metabolism , Enteroendocrine Cells/drug effects , Mice , Animals , RNA, Messenger/metabolism , Cell Line , Glucose/metabolism
5.
Food Chem ; 452: 139556, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38744133

ABSTRACT

This study explores the molecular interactions and structural changes in κ-carrageenan crosslinked with isovanillin to create a biocomposite material suitable for hard capsule and bio-degradable packaging applications. Proton Nuclear Magnetic Resonance (1H NMR) spectroscopy revealed chemical changes in the conjugate molecule, indicating improved electronegativity due to intermolecular hydrogen bonding between κ-carrageenan and isovanillin. Time-of-flight Secondary Ion Mass Spectrometry (ToF-SIMS) analysis revealed enhanced ion intensity due to intermolecular interactions, particularly between sulphate and hydrogen ions. X-ray Photoelectron Spectroscopy (XPS) study demonstrated that κ-carrageenan and isovanillin form stronger hydrogen bonds, with a shift in binding energy indicating higher electronegativity. These findings shed light on the molecular mechanisms that underpin the formation of the biocomposite material, as well as its potential for use in hard capsule and biodegradable packaging materials, addressing the need for sustainable alternatives in the pharmaceutical and packaging industries while also contributing to environmental conservation.


Subject(s)
Carrageenan , Food Packaging , Magnetic Resonance Spectroscopy , Photoelectron Spectroscopy , Spectrometry, Mass, Secondary Ion , Carrageenan/chemistry , Food Packaging/instrumentation , Hydrogen Bonding , Drug Packaging , Benzaldehydes
6.
Bioorg Chem ; 147: 107393, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38691908

ABSTRACT

Cyclooxygenase-2 plays a vital role in inflammation by catalyzing arachidonic acid conversion toward prostaglandins, making it a prime therapeutic objective. Selective COX-2 inhibitors represent significant progress in anti-inflammatory therapy, offering improved efficacy and fewer side effects. This study describes the synthesis of novel anti-inflammatory compounds from established pharmaceutically marketed agents like fenamates III-V and ibuprofen VI. Through rigorous in vitro testing, compounds 7b-c, and 12a-b demonstrated substantial in vitro selective inhibition, with IC50 values of 0.07 to 0.09 µM, indicating potent pharmacological activity. In vivo assessment, particularly focusing on compound 7c, revealed significant anti-inflammatory effects. Markedly, it demonstrated the highest inhibition of paw thickness (58.62 %) at the 5-hr mark compared to the carrageenan group, indicating its potency in mitigating inflammation. Furthermore, it exhibited a rapid onset of action, with a 54.88 % inhibition observed at the 1-hr mark. Subsequent comprehensive evaluations encompassing analgesic efficacy, histological characteristics, and toxicological properties indicated that compound 7c did not induce gastric ulcers, in contrast to the ulcerogenic tendency associated with mefenamic acid. Moreover, compound 7c underwent additional investigations through in silico methodologies such as molecular modelling, field alignment, and density functional theory. These analyses underscored the therapeutic potential and safety profile of this novel compound, warranting further exploration and development in the realm of pharmaceutical research.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal , Carrageenan , Cyclooxygenase 2 Inhibitors , Cyclooxygenase 2 , Fenamates , Ibuprofen , Ibuprofen/pharmacology , Ibuprofen/chemistry , Ibuprofen/chemical synthesis , Cyclooxygenase 2/metabolism , Animals , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2 Inhibitors/chemical synthesis , Cyclooxygenase 2 Inhibitors/chemistry , Molecular Structure , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Structure-Activity Relationship , Fenamates/pharmacology , Fenamates/chemistry , Fenamates/chemical synthesis , Dose-Response Relationship, Drug , Humans , Mice , Edema/drug therapy , Edema/chemically induced , Molecular Docking Simulation , Rats , Male
7.
Nutrients ; 16(9)2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38732613

ABSTRACT

Carrageenan is a widely used food additive and is seen as a potential candidate in the pharmaceutical industry. However, there are two faces to carrageenan that allows it to be used positively for therapeutic purposes. Carrageenan can be used to create edible films and for encapsulating drugs, and there is also interest in the use of carrageenan for food printing. Carrageenan is a naturally occurring polysaccharide gum. Depending on the type of carrageenan, it is used in regulating the composition of intestinal microflora, including the increase in the population of Bifidobacterium bacteria. On the other hand, the studies have demonstrated the harmfulness of carrageenan in animal and human models, indicating a direct link between diet and intestinal inflammatory states. Carrageenan changes the intestinal microflora, especially Akkermansia muciniphilia, degrades the mucous barrier and breaks down the mucous barrier, causing an inflammatory reaction. It directly affects epithelial cells by activating the pro-inflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) pathway. The mechanism is based on activation of the TLR4 receptor, alterations in macrophage activity, production of proinflammatory cytokines and activation of innate immune pathways. Carrageenan increases the content of Bacteroidetes bacteria, also causing a reduction in the number of short chain fatty acid (SCFA)-producing bacteria. The result is damage to the integrity of the intestinal membrane and reduction of the mucin layer. The group most exposed to the harmful effects of carrageenan are people suffering from intestinal inflammation, including Crohn disease (CD) and ulcerative colitis (UC).


Subject(s)
Carrageenan , Gastrointestinal Microbiome , Inflammatory Bowel Diseases , Humans , Animals , Gastrointestinal Microbiome/drug effects , Inflammatory Bowel Diseases/drug therapy , Akkermansia , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism
8.
Biomater Adv ; 161: 213870, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38701686

ABSTRACT

Wound healing following skin tumour surgery still remains a major challenge. To address this issue, polysaccharide-loaded nanofibrous mats have been engineered as skin patches on the wound site to improve wound healing while simultaneously eliminating residual cancer cells which may cause cancer relapse. The marine derived polysaccharides kappa-carrageenan (KCG) and fucoidan (FUC) were blended with polydioxanone (PDX) nanofibers due to their inherent anti-cancer activity conferred by the sulphate groups as well as their immunomodulatory properties which can reduce inflammation resulting in accelerated wound healing. KCG and FUC were released sustainably from the blend nanofibers via the Korsmeyer-Peppas kinetics. MTT assays, live/dead staining and SEM images demonstrated the toxicity of KCG and FUC towards skin cancer MP 41 cells. In addition, MP 41 cells showed reduced metastatic potential when grown on KCG or FUC containing mats. Both KCG and FUC were non- cytotoxic to healthy L 929 fibroblast cells. In vivo studies on healthy Wistar rats confirmed the non-toxicity of the nanofibrous patches as well as their improved and scarless wound healing potential. In vivo studies on tumour xenograft model further showed a reduction of 7.15 % in tumour volume in only 4 days following application of the transdermal patch.


Subject(s)
Melanoma , Nanofibers , Polysaccharides , Rats, Wistar , Skin Neoplasms , Tissue Scaffolds , Wound Healing , Animals , Wound Healing/drug effects , Nanofibers/chemistry , Rats , Skin Neoplasms/pathology , Melanoma/pathology , Tissue Scaffolds/chemistry , Polysaccharides/pharmacology , Polysaccharides/administration & dosage , Mice , Cell Line, Tumor , Carrageenan/pharmacology , Humans , Polydioxanone/pharmacology , Polydioxanone/chemistry , Neoplasm Recurrence, Local/prevention & control , Neoplasm Recurrence, Local/pathology
9.
Physiol Behav ; 281: 114575, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38692384

ABSTRACT

Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain accompanied by fatigue and muscle atrophy. Although its etiology is not known, studies have shown that FM patients exhibit altered function of the sympathetic nervous system (SNS), which regulates nociception and muscle plasticity. Nevertheless, the precise SNS-mediated mechanisms governing hyperalgesia and skeletal muscle atrophy in FM remain unclear. Thus, we employed two distinct FM-like pain models, involving intramuscular injections of acidic saline (pH 4.0) or carrageenan in prepubertal female rats, and evaluated the catecholamine content, adrenergic signaling and overall muscle proteolysis. Subsequently, we assessed the contribution of the SNS to the development of hyperalgesia and muscle atrophy in acidic saline-injected rats treated with clenbuterol (a selective ß2-adrenergic receptor agonist) and in animals maintained under baseline conditions and subjected to epinephrine depletion through adrenodemedullation (ADM). Seven days after inducing an FM-like model with acidic saline or carrageenan, we observed widespread mechanical hyperalgesia along with loss of strength and/or muscle mass. These changes were associated with reduced catecholamine content, suggesting a common underlying mechanism. Notably, treatment with a ß2-agonist alleviated hyperalgesia and prevented muscle atrophy in acidic saline-induced FM-like pain, while epinephrine depletion induced mechanical hyperalgesia and increased muscle proteolysis in animals under baseline conditions. Together, the results suggest that reduced sympathetic activity is involved in the development of pain and muscle atrophy in the murine model of FM analyzed.


Subject(s)
Clenbuterol , Disease Models, Animal , Fibromyalgia , Hyperalgesia , Muscular Atrophy , Sympathetic Nervous System , Animals , Female , Fibromyalgia/pathology , Fibromyalgia/physiopathology , Muscular Atrophy/pathology , Muscular Atrophy/physiopathology , Hyperalgesia/physiopathology , Hyperalgesia/pathology , Sympathetic Nervous System/physiopathology , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/pathology , Clenbuterol/pharmacology , Rats , Carrageenan/toxicity , Rats, Sprague-Dawley , Pain/pathology , Pain/physiopathology , Epinephrine , Muscle, Skeletal/pathology , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiopathology , Catecholamines/metabolism , Adrenergic beta-Agonists/pharmacology
10.
SAR QSAR Environ Res ; 35(5): 343-366, 2024 May.
Article in English | MEDLINE | ID: mdl-38776241

ABSTRACT

Most of pharmaceutical agents display a number of biological activities. It is obvious that testing even one compound for thousands of biological activities is not practically possible. A computer-aided prediction is therefore the method of choice in this case to select the most promising bioassays for particular compounds. Using the PASS Online software, we determined the probable anti-inflammatory action of the 12 new hybrid dithioloquinolinethiones derivatives. Chemical similarity search in the World-Wide Approved Drugs (WWAD) and DrugBank databases did not reveal close structural analogues with the anti-inflammatory action. Experimental testing of anti-inflammatory activity of the synthesized compounds in the carrageenan-induced inflammation mouse model confirmed the computational predictions. The anti-inflammatory activity of the studied compounds (2a, 3a-3k except for 3j) varied between 52.97% and 68.74%, being higher than the reference drug indomethacin (47%). The most active compounds appeared to be 3h (68.74%), 3k (66.91%) and 3b (63.74%) followed by 3e (61.50%). Thus, based on the in silico predictions a novel class of anti-inflammatory agents was discovered.


Subject(s)
Anti-Inflammatory Agents , Carrageenan , Quantitative Structure-Activity Relationship , Quinolines , Animals , Mice , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Quinolines/chemistry , Quinolines/pharmacology , Inflammation/drug therapy , Inflammation/chemically induced , Thiones/chemistry , Thiones/pharmacology , Male , Edema/drug therapy , Edema/chemically induced
11.
J Agric Food Chem ; 72(22): 12665-12672, 2024 Jun 05.
Article in English | MEDLINE | ID: mdl-38775811

ABSTRACT

κ-Carrageenase plays an important role in achieving the high-value utilization of carrageenan. Factors such as the reaction temperature, thermal stability, catalytic efficiency, and product composition are key considerations for its large-scale application. Previous studies have shown that the C-terminal noncatalytic domains (nonCDs) could influence the enzymatic properties, of κ-carrageenases, providing a strategy for exploring κ-carrageenases with different properties, especially catalytic products. Accordingly, two κ-carrageenases (CaKC16A and CaKC16B), from the Catenovulum agarivorans DS2, were selected and further characterized. Bioinformatics analysis suggested that CaKC16A contained a nonCD but CaKC16B did not. CaKC16A exhibited better enzymatic properties than CaKC16B, including thermal stability, substrate affinity, and catalytic efficiency. After truncation of the nonCD of CaKC16A, its thermal stability, substrate affinity, and catalytic efficiency have significantly decreased, indicating the vital role of nonCD in maintaining a good enzymatic property. Moreover, CaKC16A degraded κ-carrageenan to produce a highly single κ-neocarratetrose, while CaKC16B produced a single κ-neocarrabiose. CaKC16A could degrade ß/κ-carrageenan to produce a highly single desulfated κ-neocarrahexaose, while CaKC16B produced κ-neocarrabiose and desulfated κ-neocarratetrose. Furthermore, it was proposed that CaKC16A and CaKC16B participate in the B/KC metabolic pathway and serve different roles, providing new insight into obtaining κ-carrageenases with different properties.


Subject(s)
Bacterial Proteins , Carrageenan , Enzyme Stability , Glycoside Hydrolases , Carrageenan/metabolism , Carrageenan/chemistry , Glycoside Hydrolases/metabolism , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/genetics , Bacterial Proteins/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Substrate Specificity , Kinetics , Temperature
12.
Int J Biol Macromol ; 270(Pt 2): 132464, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38772469

ABSTRACT

A series of intelligent films with pH-responsive properties were prepared using Padus virginiana peel extract (PVE) as a smart response factor, κ-carrageenan (κC) as a matrix, and complexed with rice straw lignin (SL). Following the addition of 5 mL PVE at a concentration of 430.99 mg/L, tensile strength and elongation at break of the films increased to a maximum value of 21.25 ± 0.75 MPa and 24.04 ± 0.69 %, respectively. The water vapour permeability of the films decreased with increasing PVE addition, and the minimum value was 5.85 ± 0.09 × 10-11 g m-1 s-1 Pa-1. All the films had favourable thermal stability, transparency, haze and antioxidant properties. PVE-containing films all exhibited excellent pH and ammonia response properties. The higher the humidity of the environment, the faster the ammonia response, and the films were capable of rapid discoloration at 75 % relative humidity. κC/SL-PVE5 can be used to monitor the freshness of chicken breast meat. When the total volatile basic nitrogen of chicken breast meat was increased to 14.27 mg/100 g, κC/SL-PVE5 changed from pink to greyish-yellow. In conclusion, κC/SL-PVE intelligent films hold great promise for real-time monitoring of meat freshness.


Subject(s)
Anthocyanins , Carrageenan , Chickens , Lignin , Carrageenan/chemistry , Animals , Lignin/chemistry , Anthocyanins/chemistry , Hydrogen-Ion Concentration , Food Packaging/methods , Antioxidants/chemistry , Permeability , Meat/analysis , Tensile Strength , Steam
13.
World J Microbiol Biotechnol ; 40(7): 216, 2024 May 28.
Article in English | MEDLINE | ID: mdl-38802708

ABSTRACT

Poor thermostability reduces the industrial application value of κ-carrageenase. In this study, the PoPMuSiC algorithm combined with site-directed mutagenesis was applied to improve the thermostability of the alkaline κ-carrageenase from Pseudoalteromonas porphyrae. The mutant E154A with improved thermal stability was successfully obtained using this strategy after screening seven rationally designed mutants. Compared with the wild-type κ-carrageenase (WT), E154A improved the activity by 29.4% and the residual activity by 51.6% after treatment at 50 °C for 30 min. The melting temperature (Tm) values determined by circular dichroism were 66.4 °C and 64.6 °C for E154A and WT, respectively. Molecular dynamics simulation analysis of κ-carrageenase showed that the flexibility decreased within the finger regions (including F1, F2, F3, F5 and F6) and the flexibility improved in the catalytic pocket area of the mutant E154A. The catalytic tunnel dynamic simulation analysis revealed that E154A led to enlarged catalytic tunnel volume and increased rigidity of the enzyme-substrate complex. The increasing rigidity within the finger regions and more flexible catalytic pocket of P. porphyrae κ-carrageenase might be a significant factor for improvement of the thermostability of the mutant κ-carrageenase E154A. The proposed rational design strategy could be applied to improve the enzyme kinetic stability of other industrial enzymes. Moreover, the hydrolysates of κ-carrageenan digested by the mutant E154A demonstrated increased scavenging activities against hydroxyl (OH) radicals and 2,2'-azinobis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) radicals compared with the undigested κ-carrageenan.


Subject(s)
Catalytic Domain , Enzyme Stability , Glycoside Hydrolases , Molecular Dynamics Simulation , Mutagenesis, Site-Directed , Pseudoalteromonas , Glycoside Hydrolases/genetics , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/metabolism , Pseudoalteromonas/enzymology , Pseudoalteromonas/genetics , Bacterial Proteins/genetics , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Kinetics , Temperature , Circular Dichroism , Protein Conformation , Carrageenan/metabolism
14.
Int J Biol Macromol ; 270(Pt 1): 132062, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38705340

ABSTRACT

Oral drug administration, especially when composed of mucoadhesive delivery systems, has been a research trend due to increased residence time and contact with the mucosa, potentially increasing drug bioavailability and stability. In this context, this study aimed to develop self-assembly mucoadhesive beads composed of blends of κ-carrageenan and sericin (κ-Car/Ser) loaded with the anti-inflammatory drug indomethacin (IND). We investigated the swelling, adhesion behaviour, and mechanical/physical properties of the beads, assessing their effects on cell viability, safety and permeation characteristics in both 2D and triple-culture model. The swelling ratio of the beads indicated pH-responsiveness, with maximum water absorption at pH 6.8, and strong mucoadhesion, increasing primarily with higher polymer concentrations. The beads exhibited thermal stability and no chemical interaction with IND, showing improved mechanical properties. Furthermore, the beads remained stable during accelerated and long-term storage studies. The beads were found to be biocompatible, and IND encapsulation improved cell viability (>70 % in both models, 79 % in VN) and modified IND permeation through the models (6.3 % for F5 formulation (κ-Car 0.90 % w/v | Ser 1.2 % w/v| IND 3.0 g); 10.9 % for free IND, p < 0.05). Accordingly, κ-Car/Ser/IND beads were demonstrated to be a promising IND drug carrier to improve oral administration while mitigating the side effects of non-steroidal anti-inflammatories.


Subject(s)
Carrageenan , Delayed-Action Preparations , Indomethacin , Sericins , Indomethacin/chemistry , Indomethacin/administration & dosage , Indomethacin/pharmacokinetics , Carrageenan/chemistry , Administration, Oral , Humans , Sericins/chemistry , Delayed-Action Preparations/chemistry , Drug Carriers/chemistry , Drug Liberation , Cell Survival/drug effects , Microspheres , Animals , Caco-2 Cells , Hydrogen-Ion Concentration
15.
Int J Biol Macromol ; 270(Pt 1): 131758, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38714282

ABSTRACT

In this study, the whey protein concentrate and xanthan gum complex obtained by specific pH treatment, along with κ-carrageenan (KC), were used to encapsulate Lactobacillus acidophilus JYLA-191 in an emulsion gel system. The effects of crosslinking and KC concentration on the visual characteristics, stability, mechanical properties, and formation mechanism of emulsion gels were investigated. The results of optical imaging, particle size distribution, and rheology exhibited that with the addition of crosslinking agents, denser and more homogeneous emulsion gels were formed, along with a relative decrease in the droplet size and a gradual increase in viscosity. Especially when the concentration of citric acid (CA) was 0.09 wt%, KC was 0.8 wt%, and K+ was present in the system, the double-network emulsion gel was stable at high temperatures and in freezing environments, and the swelling ratio was the lowest (9.41%). Gastrointestinal tract digestive treatments and pasteurization revealed that the probiotics encapsulated in the double-network emulsion gel had a higher survival rate, which was attributed to the synergistic cross-linking of CA and K+ biopolymers to construct the emulsion gels. Overall, this study highlights the potential of emulsion gels to maintain probiotic vitality and provides valuable insights for developing inventive functional foods.


Subject(s)
Carrageenan , Emulsions , Gels , Lactobacillus acidophilus , Polysaccharides, Bacterial , Probiotics , Whey Proteins , Polysaccharides, Bacterial/chemistry , Polysaccharides, Bacterial/pharmacology , Carrageenan/chemistry , Carrageenan/pharmacology , Emulsions/chemistry , Probiotics/chemistry , Whey Proteins/chemistry , Whey Proteins/pharmacology , Gels/chemistry , Lactobacillus acidophilus/drug effects , Rheology , Microbial Viability/drug effects , Particle Size , Viscosity
16.
Int J Biol Macromol ; 270(Pt 1): 132264, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38734340

ABSTRACT

The low water solubility and inadequate bioavailability of curcumin significantly hinder its broad biological applications in the realms of food and medicine. There is limited information currently available regarding the particle characteristics and functional capabilities of zein-lysozyme-based nanomaterials. Thereby, the primary goal of the current work is to effectively develop innovative zein-lysozyme-κ-carrageenan complex nanocomposites (ZLKC) as a reliable carrier for curcumin encapsulation. As a result, ZLKC nanoparticles showed a smooth spherical nanostructure with improved encapsulation efficiency. Fourier-transform infrared, fluorescence spectroscopy, dissociation assay, and circular dichroism analysis revealed that hydrophobic and electrostatic interactions and hydrogen bonding were pivotal in the construction and durability of these composites. X-ray diffraction examination affirmed the lack of crystallinity in curcumin encapsulated within nanoparticles. The incorporation of κ-carrageenan significantly improved the physicochemical stability of ZLKC nanoparticles in diverse environmental settings. Additionally, ZLKC nanocomposites demonstrated enhanced antioxidant and antimicrobial properties, as well as sustained release characteristics. Therefore, these findings demonstrate the potential application of ZLKC nanocomposites as delivery materials for encapsulating bioactive substances.


Subject(s)
Carrageenan , Curcumin , Muramidase , Nanocomposites , Zein , Curcumin/chemistry , Zein/chemistry , Carrageenan/chemistry , Nanocomposites/chemistry , Muramidase/chemistry , Antioxidants/chemistry , Antioxidants/pharmacology , Drug Carriers/chemistry , Drug Liberation , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Drug Compounding
17.
Int J Biol Macromol ; 270(Pt 2): 132309, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38740157

ABSTRACT

The development of biopolymer-based filtration systems for water remediation applications is an extremely fascinating area of research. In this paper, we developed a biopolymer-based filtration system using sodium alginate (NaAlg) and carrageenan (Car) for the removal of the toxic cationic dye, methylene blue (MB). The membrane's properties were assessed using FTIR, TGA, UTM, FESEM, EDS, XRD, and water uptake, revealing commendable thermomechanical stability (5.79 MPa), good hydrophilicity, and compatibility. The experimental results further revealed that lambda Car/calcium alginate (λ-Car/CaAlg) exhibited superior dye rejection (100%) and flux (11.67 L m-2 h-1) compared to kappa Car/CaAlg (κ-Car/CaAlg) (99.22% and 11.19 L m-2 h-1) and plain alginate (CaAlg) (99.63% and 9.79 L m-2 h-1). The high MB rejection rate was attributed to the sieving mechanism and electrostatic interaction. A rejection rate of 100% was achieved at an initial MB concentration of 10 mg/L, pressure of 0.1 MPa, pH of 7, and temperature of 25°C. Furthermore, the hydrogel membranes demonstrated excellent recyclability over nine cycles, indicating their potential for water treatment applications.


Subject(s)
Alginates , Carrageenan , Coloring Agents , Membranes, Artificial , Water Purification , Alginates/chemistry , Carrageenan/chemistry , Water Purification/methods , Coloring Agents/chemistry , Coloring Agents/isolation & purification , Hydrogels/chemistry , Filtration/methods , Water Pollutants, Chemical/chemistry , Water Pollutants, Chemical/isolation & purification , Methylene Blue/chemistry , Methylene Blue/isolation & purification , Cations/chemistry , Hydrogen-Ion Concentration
18.
Int J Biol Macromol ; 270(Pt 1): 132343, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38750841

ABSTRACT

Color indicator films incorporating aronia extract powder (AEP) and biopolymers like agar, carrageenan, and cellulose nanofiber (CNF) were developed to monitor kimchi freshness. AEP-containing films showed strong UV-barrier properties, and reduced light transmittance by 99.12 % for agar, 98.86 % for carrageenan, and 98.67 % for CNF-based films. All AEP-films exhibited high sensitivity to pH changes and vapor exposure to ammonia and acetic acid. Color change notably influenced by the polymer type, particularly evident with ammonia vapor exposure, especially in the AEP/carrageenan film. The chemical structure and thermal stability of the biopolymers remained unchanged after AEP-addition. Tensile strength increased by 24.2 % for AEP/CNF but decreased by 19.4 % for AEP/agar and 24.3 % for AEP/carrageenan films. AEP-containing films displayed strong antioxidant activity, with 99 % free radical scavenging in ABTS and ~ 80 % in DPPH assays. Alkalized AEP-indicator films were more effective in detecting color changes during kimchi packaging tests. Among the labels, alkalized AEP/agar film showed the most obvious color change from green-gray (fresh kimchi, pH 5.5, acidity 0.48 %) to pale brown (optimal fermentation, pH 4.6, acidity 0.70 %), and pale violet-brown (over-fermented, pH 3.80, acidity 1.35 %). Alkalized AEP-indicator films offer promising real-time detection of packed fermented foods like kimchi.


Subject(s)
Agar , Carrageenan , Cellulose , Colorimetry , Food Packaging , Nanofibers , Plant Extracts , Carrageenan/chemistry , Nanofibers/chemistry , Agar/chemistry , Cellulose/chemistry , Colorimetry/methods , Food Packaging/methods , Plant Extracts/chemistry , Antioxidants/chemistry , Antioxidants/analysis , Tensile Strength , Color , Hydrogen-Ion Concentration
19.
Int J Biol Macromol ; 270(Pt 2): 132385, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38754668

ABSTRACT

CNCs are intensively studied to reinforce biocomposites. However, it remains a challenge to homogeneously disperse the CNC in biocomposites for a smooth film surface. Mechanochemical treatment via ultrasonication in deep eutectic solvent (DES) generated a stable dispersion of CNC before incorporation into carrageenan biocomposite. Shifted peaks of choline chloride (ChCl) methylene groups to 3.95-3.98 ppm in 1H NMR indicated a formation of eutectic mixture between the hydrogen bond acceptor (HBA) and hydrogen bond donor (HBD) at the functional group of CH3···OH. The swelling of CNC in the DES was proven by the formation of intermolecular H-bond at a length of 2.46 Å. The use of DES contributed to a good dispersion of CNC in the solution which increased zeta potential by 43.2 % compared to CNC in deionized water. The ultrasonication amplitude and feed concentration were varied for the best parameters of a stable dispersion of CNC. The crystallinity of 1 wt% of CNC at 20 % sonication amplitude improved from 76 to 81 %. The high crystallinity of CNCDES resulted in an increase in film tensile and capsule loop strength of Carra-CNCDES by 20.7 and 19.4 %, respectively. Improved dispersion of CNCDES reduced the surface roughness of the biocomposite by 21.8 %. H-bond network in CNCDES improved the biocomposite properties for an ingenious reinforcement material.


Subject(s)
Carrageenan , Cellulose , Nanoparticles , Carrageenan/chemistry , Cellulose/chemistry , Nanoparticles/chemistry , Sonication/methods , Hydrogen Bonding , Solvents/chemistry , Tensile Strength , Biocompatible Materials/chemistry
20.
Int J Biol Macromol ; 270(Pt 1): 132379, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38754680

ABSTRACT

Hydrogels based on natural polysaccharides have demonstrated efficacy in epithelial recovery from cutaneous burn wounds. Here, we prepared a double-network hydrogel consisting of galactomannan (from Cassia grandis seeds) and κ-carrageenan (commercially sourced), cross-linked with CaCl2, as a matrix for immobilizing lactoferrin and/or Cramoll, aiming at its applicability as dressings for second-degree burn wounds. The formulations obtained [H - hydrogel, HL - hydrogel + lactoferrin, HC - hydrogel + Cramoll and HLC - hydrogel + lactoferrin + Cramoll] were analyzed rheologically as well as in terms of their stability (pH, color, microbial contamination) for 90 days. The burn was created with an aluminum bar (97 ± 3 °C) in the dorsal region of Wistar rats and subsequently treated with hydrogels (H, HL, HC, HLC) and control saline solution (S). The burn was monitored for 3, 7 and 14 days to evaluate the efficacy of the hydrogels in promoting wound healing. The hydrogels did not reveal significant pH or microbiological changes; there was an increase in brightness and a reduction in opacity for H. The rheological analysis confirmed the gel-like viscoelastic signature of the systems without substantial modification of the basic rheological characteristics, however HLC proved to be more rigid, due to rheological synergy when combining protein biomolecules. Macroscopic analyses confirmed centripetal healing with wound contraction: S < H < HC < HL < HLC. Histopathological analyses showed that hydrogel-treated groups reduced inflammation, tissue necrosis and fibrosis, while promoting re-epithelialization with focal acanthosis, especially in HLC due to a positive synergistic effect, indicating its potential as a promising therapy in the repair of burns.


Subject(s)
Burns , Carrageenan , Galactose , Hydrogels , Mannans , Rats, Wistar , Wound Healing , Hydrogels/chemistry , Mannans/chemistry , Mannans/pharmacology , Animals , Burns/therapy , Burns/drug therapy , Carrageenan/chemistry , Wound Healing/drug effects , Rats , Galactose/analogs & derivatives , Galactose/chemistry , Male , Lactoferrin/chemistry , Rheology
SELECTION OF CITATIONS
SEARCH DETAIL
...